GMED Earnings

GMED reported its earnings on 2026-02-24, showcasing a revenue of 826.42M against an estimate of 787.85M, resulting in a 4.9% surprise. The EPS was 1.28, surpassing the expected 1.06 by 20.75%. The stock experienced a 4.72% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following GMED's earnings announcement on 2026-02-24, the stock price moved by 4.72% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, GMED's stock price tends to shift by an average of 1.21% in the 10 days leading up to earnings and 5.6% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate GMED's annual revenue to reach 725.83M, while the EPS is projected at 0.90. These estimates reflect recent revisions, with revenue estimates revised upward by 0.1% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between GMED's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.1%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GMED's stock price typically moves by 1.21% in the 10 days before its earnings and 5.6% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.90 and revenue of 725.83M.

The earnings call summary shows strong financial performance with significant year-over-year growth in revenue, gross margin, operating income, and net income. The increase in revenue guidance and EPS guidance for 2025 further supports a positive outlook. The absence of explicit or implied risks and the lack of negative sentiment in the Q&A section also contribute to the positive sentiment. However, the lack of discussion on shareholder returns and operational updates prevents a 'Strong positive' rating.